Morgantown, WV, United States of America

Peter Bruce Bottini


 

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Peter Bruce Bottini: Innovator in Cardiovascular Treatments**

Introduction

Peter Bruce Bottini is a notable inventor based in Morgantown, West Virginia, who has made significant contributions to the field of pharmaceuticals. He holds two patents that demonstrate his commitment to advancing medical treatments, specifically in cardiovascular care.

Latest Patents

Among his most recent innovations, Bottini has developed compositions comprising nebivolol. Nebivolol is recognized for its efficacy in treating cardiovascular diseases such as hypertension, congestive heart failure, arterial stiffness, and endothelial dysfunction. The patented pharmaceutical composition includes nebivolol alongside at least one other active cardiovascular agent, amplifying its therapeutic benefits.

Career Highlights

Bottini works with Forest Laboratories Holdings Limited, where he plays an integral role in developing new pharmaceutical solutions. His work focuses primarily on improving cardiovascular health through innovative drug formulations and therapeutic strategies.

Collaborations

Throughout his career, Bottini has collaborated with esteemed colleagues, including Eric Davis and John P. O'Donnell. These partnerships have been pivotal in advancing his research and enhancing the effectiveness of his inventions in the pharmaceutical industry.

Conclusion

With a commitment to improving health outcomes through innovation, Peter Bruce Bottini continues to contribute to the pharmaceutical field. His work, particularly in the development of compositions containing nebivolol, showcases the potential for novel treatments that can address critical cardiovascular issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…